A replenishable peritoneal implant for localised delivery and peritoneal fluid sampling for ovarian cancer

Read full text Summarise with VIRAT
Authors: Alyce Sheedy, Mihir Shetty, Anna Weis, Laura E. Bendzick, Terran D Stenger, Zhenya Ni, Philippa R Kennedy, Jacob A. Myers, Niamh Ward, Lesley Trask, Hannah Prendeville, Joanne O’Dwyer
+7 more Michael O’Dwyer, Ellen Tunney Roche, Garry P. Duffy, Jeffrey S. Miller, Melissa Ann Geller, Eimear B. Dolan, Martin Felices
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Intraperitoneal (i.p.) therapy improves outcomes in abdominal cancers but remains underutilized due to complications from repurposed catheters. In this work, we present a replenishable therapeutic implant for repeated, localized delivery of therapies to the peritoneal cavity. In an ovarian cancer mouse model, expanded natural killer (eNK) cells were delivered once weekly and interleukin-15 (IL-15) thrice weekly. This regime reduced tumor burden compared to standard i.p. injection. The implant supports co-administration of chemotherapy, cytokines, monoclonal antibodies, or other protein-based therapies. Negative pressure applied via the port enabled longitudinal sampling of peritoneal fluid without additional surgical intervention. By reducing procedural burden and improving adaptability, the implant can help increase patient retention and therapeutic efficacy in ovarian cancer and other intra-abdominal cancers.

Fields of Study & Subjects

Ovarian cancer diagnosis and treatment Intraperitoneal and Appendiceal Malignancies Tissue Engineering and Regenerative Medicine

Publication details

Journal / source
Research Repository UCD (University College Dublin)
Publication date
1 January 2026
Language
UND